Physician profile
Andrzej P Torbus
NPI 1699070441
$4,379.17
in general payments reported to CMS, 2019-2025
35 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,349 · 2020: $960 · 2021: $1,111 · 2022: $294 · 2023: $255 · 2024: $223 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $665.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $905.17 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Amarin Pharma, INC. | $566.25 | 2019-2022 | |
| Allergan, INC. | $371.03 | 2019-2020 | |
| Lilly USA, LLC | $328.59 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Abbvie INC. | $276.44 | 2021-2023 | Vraylar |
| Merck Sharp & Dohme LLC | $244.09 | 2019-2024 | Gardasil, Gardasil 9, Capvaxive |
| Takeda Pharmaceuticals U.S.A., INC. | $231.23 | 2019-2024 | Trintellix |
| Astrazeneca Pharmaceuticals LP | $184.60 | 2019-2022 | |
| Horizon Therapeutics Plc | $170.59 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.81 | 2019-2022 | |
| Pfizer INC. | $122.16 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $89.21 | 2019-2022 | |
| Glaxosmithkline, LLC. | $85.00 | 2021-2025 | Arexvy, Shingrix |
| Exact Sciences Corporation | $73.71 | 2024-2025 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $64.13 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $62.22 | 2019-2023 | Veozah |
| Amgen INC. | $53.35 | 2019-2020 | |
| Abbott Laboratories | $49.51 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Esperion Therapeutics, INC. | $40.23 | 2020-2022 | |
| Avanir Pharmaceuticals, INC. | $37.60 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $37.41 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.85 | 2024-2025 | Xifaxan, Trulance |
| Janssen Pharmaceuticals, INC | $26.74 | 2019 | |
| Dexcom, INC. | $21.31 | 2025 | Dexcom G6 Transmitter |
| Corium, LLC | $16.51 | 2023 | Azstarys |
| Ibsa Pharma INC. | $15.01 | 2025 | Tirosint, Licart, Flector |
| Idorsia Pharmaceuticals US INC | $15.00 | 2023 | Quviviq |
| Dynavax Technologies Corporation | $13.95 | 2021 | |
| Genentech USA, INC. | $13.50 | 2020 | |
| Daiichi Sankyo INC. | $13.07 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.99 | 2019 | |
| Eisai INC. | $12.96 | 2021 | |
| Ironwood Pharmaceuticals, INC | $12.70 | 2020 | |
| Biogen, INC. | $12.25 | 2021 | |
| Sanofi Pasteur INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrzej Torbus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.